Search

Search Constraints

You searched for: Author/Creator Vangjeli, Ciara

Search Results

1. Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A2 formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). (February 2018)

3. Phenome-wide association studies across large population cohorts support drug target validation. Issue 1 (December 2018)

4. Sclerostin Downregulation Globally by Naturally Occurring Genetic Variants, or Locally in Atherosclerotic Plaques, Does Not Associate With Cardiovascular Events in Humans. (30th March 2021)